179 related articles for article (PubMed ID: 22791787)
21. Time to improve statin prescription guidelines in low-risk patients?
Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
[TBL] [Abstract][Full Text] [Related]
22. Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data.
Matthews A; Herrett E; Gasparrini A; Van Staa T; Goldacre B; Smeeth L; Bhaskaran K
BMJ; 2016 Jun; 353():i3283. PubMed ID: 27353418
[TBL] [Abstract][Full Text] [Related]
23. Predictors of cholesterol treatment discussions and statin prescribing for primary cardiovascular disease prevention in community health centers.
Karmali KN; Lee JY; Brown T; Persell SD
Prev Med; 2016 Jul; 88():176-81. PubMed ID: 27090436
[TBL] [Abstract][Full Text] [Related]
24. Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.
Wu J; Zhu S; Yao GL; Mohammed MA; Marshall T
PLoS One; 2013; 8(7):e67611. PubMed ID: 23922649
[TBL] [Abstract][Full Text] [Related]
25. Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial.
Persell SD; Lloyd-Jones DM; Friesema EM; Cooper AJ; Baker DW
J Gen Intern Med; 2013 Apr; 28(4):554-60. PubMed ID: 23143672
[TBL] [Abstract][Full Text] [Related]
26. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.
Marcus ME; Manne-Goehler J; Theilmann M; Farzadfar F; Moghaddam SS; Keykhaei M; Hajebi A; Tschida S; Lemp JM; Aryal KK; Dunn M; Houehanou C; Bahendeka S; Rohloff P; Atun R; Bärnighausen TW; Geldsetzer P; Ramirez-Zea M; Chopra V; Heisler M; Davies JI; Huffman MD; Vollmer S; Flood D
Lancet Glob Health; 2022 Mar; 10(3):e369-e379. PubMed ID: 35180420
[TBL] [Abstract][Full Text] [Related]
27. Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population.
Rodriguez F; Olufade TO; Ramey DR; Friedman HS; Navaratnam P; Heithoff K; Foody JM
J Womens Health (Larchmt); 2016 Jul; 25(7):697-706. PubMed ID: 26889924
[TBL] [Abstract][Full Text] [Related]
28. Age, sex and practice variations in the use of statins in general practice in England and Wales.
Majeed A; Moser K; Maxwell R
J Public Health Med; 2000 Sep; 22(3):275-9. PubMed ID: 11077897
[TBL] [Abstract][Full Text] [Related]
29. Statins for secondary cardiovascular disease prevention for older primary care patients.
Niska R; Han B
J Natl Med Assoc; 2009 Jul; 101(7):705-10. PubMed ID: 19634592
[TBL] [Abstract][Full Text] [Related]
30. Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.
Ashworth M; Lloyd D; Smith RS; Wagner A; Rowlands G
J Public Health (Oxf); 2007 Mar; 29(1):40-7. PubMed ID: 17071815
[TBL] [Abstract][Full Text] [Related]
31. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
[TBL] [Abstract][Full Text] [Related]
32. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012-2018).
Liu Y; Lv X; Xie N; Fang Z; Ren W; Gong Y; Jin Y; Zhang J
BMC Cardiovasc Disord; 2020 Apr; 20(1):201. PubMed ID: 32334525
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and costs of treating uncomplicated stage 1 hypertension in primary care: a cross-sectional analysis.
Sheppard JP; Fletcher K; McManus RJ; Mant J
Br J Gen Pract; 2014 Oct; 64(627):e641-8. PubMed ID: 25267050
[TBL] [Abstract][Full Text] [Related]
34. Trends in statin prescription prevalence, initiation, and dosing: Hong Kong, 2004-2015.
Blais JE; Chan EW; Law SWY; Mok MT; Huang D; Wong ICK; Siu CW
Atherosclerosis; 2019 Jan; 280():174-182. PubMed ID: 30529830
[TBL] [Abstract][Full Text] [Related]
35. Evaluating quality and its determinants in lipid control for secondary prevention of heart disease and stroke in primary care: a study in an inner London Borough.
Dodhia H; Kun L; Logan Ellis H; Crompton J; Wierzbicki AS; Williams H; Hodgkinson A; Balazs J
BMJ Open; 2015 Dec; 5(12):e008678. PubMed ID: 26656014
[TBL] [Abstract][Full Text] [Related]
36. Statin Prescribing Patterns: An Analysis of Data From Patients With Diabetes in the National Hospital Ambulatory Medical Care Survey Outpatient Department and National Ambulatory Medical Care Survey Databases, 2005-2010.
Pauff BR; Jiroutek MR; Holland MA; Sutton BS
Clin Ther; 2015 Jun; 37(6):1329-39. PubMed ID: 25869626
[TBL] [Abstract][Full Text] [Related]
37. Gaps in antihypertensive and statin treatments and benefits of optimisation: a modelling study in a 1 million ethnically diverse urban population in UK.
Wu R; Rison SCG; Raisi-Estabragh Z; Dostal I; Carvalho C; Robson J; Mihaylova B
BMJ Open; 2021 Dec; 11(12):e052884. PubMed ID: 35536740
[TBL] [Abstract][Full Text] [Related]
38. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
Patel A; Cass A; Peiris D; Usherwood T; Brown A; Jan S; Neal B; Hillis GS; Rafter N; Tonkin A; Webster R; Billot L; Bompoint S; Burch C; Burke H; Hayman N; Molanus B; Reid CM; Shiel L; Togni S; Rodgers A;
Eur J Prev Cardiol; 2015 Jul; 22(7):920-30. PubMed ID: 24676715
[TBL] [Abstract][Full Text] [Related]
39. Estimated Cardiovascular Risk and Guideline-Concordant Primary Prevention With Statins: Retrospective Cross-Sectional Analyses of US Ambulatory Visits Using Competing Algorithms.
Fairman KA; Romanet D; Early NK; Goodlet KJ
J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):27-36. PubMed ID: 31353942
[TBL] [Abstract][Full Text] [Related]
40. The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study.
Marshall T
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):523-8. PubMed ID: 16874140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
